Still Hungry on Mounjaro 2.5mg — Is That Normal?

The misconception worth correcting first: 2.5mg is not a therapeutic dose

A lot of people start Mounjaro expecting immediate appetite suppression and feel let down when it doesn't arrive in week one or two. It's one of the most common concerns our prescribers hear. The truth is that 2.5mg sits outside the range where tirzepatide's appetite effects become clinically meaningful for most adults. It exists entirely to ease your body into the medicine, to reduce the nausea, vomiting and other gastrointestinal effects that can follow a standing start at a higher dose.

Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, involved in appetite signalling and gastric emptying. At 2.5mg, that activation is real but modest. The slower gastric emptying that makes food feel more filling, and the hormonal signals that reduce hunger between meals, are both present, just not at the level needed to produce obvious appetite suppression for the majority of people. The NHS patient information on tirzepatide confirms that treatment starts at 2.5mg for tolerability, with dose increases every four weeks under clinical guidance.

So if you typed "mounjaro 2.5 still hungry" into a search engine at 10pm wondering whether you've been sold a sugar pill: you haven't. You're on the adjustment step, and the appetite change most people describe (food becoming less interesting, portions feeling smaller, the urge to snack fading) tends to arrive from 5mg upwards. You need to get there first.

What tends to happen to hunger as the dose increases

The SURMOUNT-1 trial, published in the New England Journal of Medicine, studied tirzepatide across its full dose range up to 15mg in adults with obesity. The weight reductions reported (around 20–21% of body weight on average at the highest maintenance dose) were built over 72 weeks of stepped titration, not from the first pen. That context matters when you're four weeks in and still raiding the cupboard after dinner.

People who've moved through the dose ladder often describe a clear shift somewhere between 5mg and 7.5mg. Meals start to feel more satisfying with less food. The background hum of hunger that most people living with obesity describe as near-constant quietens. Some find it happens earlier; for others it's gradual rather than sudden. None of that happens at 2.5mg, and that's fine, because it's not supposed to. If you're curious about what that shift looks like from the next step up, hunger on Mounjaro 5mg is explored separately.

What does matter at 2.5mg is building the habits that support later stages: eating slowly, prioritising protein at each meal, drinking enough water. These aren't filler advice. When appetite suppression arrives at a higher dose, people who've already shifted their eating patterns tend to find it easier to work with.

Practical reasons you might feel hungrier than expected, and what helps

Beyond dose, there are a few reasons hunger at 2.5mg can feel more pronounced than you expected. Stress and poor sleep both raise ghrelin, the hormone that drives appetite, and can override even moderate GLP-1 activity. Eating very quickly or choosing low-protein, high-refined-carbohydrate meals can also undercut the modest gastric-emptying effect tirzepatide offers at this dose.

A concrete routine that helps many people: keeping the pen in the fridge door (where you'll see it on Sunday mornings as a dose reminder) and pairing the injection week with a deliberate check-in on how you're eating, not a diet, just a check. Are meals mostly protein and vegetables? Are you drinking water between meals rather than eating when thirsty? These are the levers you actually control at 2.5mg.

It's also worth noting that some people experience a brief increase in appetite in the first week of any new dose, as the body adjusts. If that's what you're experiencing, it tends to settle. If it doesn't, or if anything else concerns you, your prescriber is the right person to speak to, not a forum, not a dosing guide online. For a broader look at what tirzepatide involves across its full dose range, the Mounjaro treatment overview covers the full picture. On questions about cost and what's included in private treatment, the Mounjaro pricing page sets out the context honestly.

When it might be worth raising with your prescriber

Hunger alone at 2.5mg is expected and not a reason to escalate early. The titration schedule (typically four weeks at each dose before moving up) is calibrated to balance tolerability against effect, and skipping steps because appetite hasn't shifted yet tends to increase side-effect risk without proportionally improving outcomes.

There are situations worth flagging, though. If hunger is accompanied by significant gastrointestinal side effects that aren't settling, or if you're finding the 2.5mg period much harder than anticipated, your prescriber needs to know. Equally, if you reach 5mg and the pattern continues unchanged, hunger persisting at higher doses may warrant a different clinical conversation, and for those who have moved further along the titration ladder, still feeling hungry at 12.5mg is something our prescribers can also review with you. The prescriber's job is to review the whole picture, not just the dose, but how your body is responding, and whether the titration pace is right for you.

Mounjaro is a prescription-only medicine, and every dose increase at nume is clinically reviewed before it's approved. That review isn't a formality; it's where questions like this get answered properly, by a real prescriber who has read your notes. Some patients also ask whether the hormonal changes involved in treatment have broader effects, and our page on whether Mounjaro increases fertility addresses that question honestly for anyone who wants to understand it before starting. If you haven't yet started and want to understand whether Mounjaro is suitable for you, checking your eligibility with a free consultation is the place to begin.